4.5 Article

Anticoagulant prescribing for atrial fibrillation and risk of incident dementia

Journal

HEART
Volume 107, Issue 23, Pages 1898-1904

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/heartjnl-2021-319672

Keywords

-

Funding

  1. Wellcome [201440/Z/16/Z]
  2. Wellcome Trust [201440/Z/16/Z] Funding Source: Wellcome Trust

Ask authors/readers for more resources

Among patients with newly diagnosed atrial fibrillation, treatment with direct oral anticoagulants (DOACs) was associated with a reduced incidence of dementia and mild cognitive impairment, with a 16% reduction in dementia diagnosis and a 26% reduction in incident MCI compared to treatment with Vitamin K antagonists (VKAs).
Objective The aim of this study was to investigate the association between oral anticoagulant type (direct oral anticoagulants (DOACs) vs vitamin K antagonists (VKAs)) and incident dementia or mild cognitive impairment (MCI) among patients with newly diagnosed atrial fibrillation (AF). Methods Using linked electronic health record (EHR) data from the Clinical Practice Research Datalink in the UK, we conducted a historical cohort study among first-time oral anticoagulant users with incident non-valvular AF diagnosed from 2012 to 2018. We compared the incidence of (1) clinically coded dementia and (2) MCI between patients prescribed VKAs and DOACs using Cox proportional hazards regression models, with age as the underlying timescale, accounting for calendar time and time on treatment, sociodemographic and lifestyle factors, clinical comorbidities and medications. Results Of 39 200 first-time oral anticoagulant users (44.6% female, median age 76 years, IQR 68-83), 20 687 (53%) were prescribed a VKA and 18 513 (47%) a DOAC at baseline. Overall, 1258 patients (3.2%) had GP-recorded incident dementia, incidence rate 16.5 per 1000 person-years. DOAC treatment for AF was associated with a 16% reduction in dementia diagnosis compared with VKA treatment in the whole cohort (adjusted HR 0.84, 95% CI: 0.73 to 0.98) and with a 26% reduction in incident MCI (adjusted HR 0.74, 95% CI: 0.65 to 0.84). Findings were similar across various sensitivity analyses. Conclusions Incident EHR-recorded dementia and MCI were less common among patients prescribed DOACs for new AF compared with those prescribed VKAs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available